Albert Lowe
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Albert Lowe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Initiates: Buy | $11 | $4.04 | +172.28% | 1 | Oct 9, 2024 | |
| CRDF Cardiff Oncology | Initiates: Buy | $8 | $3.74 | +113.90% | 1 | Sep 6, 2024 | |
| LCTX Lineage Cell Therapeutics | Initiates: Buy | $4 | $0.84 | +376.99% | 1 | Aug 20, 2024 | |
| SKYE Skye Bioscience | Initiates: Buy | $18 | $5.44 | +230.88% | 1 | Jul 9, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $6 | $1.64 | +265.85% | 1 | May 13, 2024 |
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $4.04
Upside: +172.28%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $3.74
Upside: +113.90%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $0.84
Upside: +376.99%
Skye Bioscience
Jul 9, 2024
Initiates: Buy
Price Target: $18
Current: $5.44
Upside: +230.88%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.64
Upside: +265.85%